Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia.

Rachel Song Varinder Jeet Rajan Sharma Martin Hoyle Bonny Parkinson

Published in: PharmacoEconomics (2022)

PSMA PET/CT is likely to be more costly than CT+WBBS or CT alone in Australia; however, it is still likely to be considered cost effective compared with conventional imaging.

Keyphrases

pet ct
positron emission tomography
prostate cancer
computed tomography
radical prostatectomy
dual energy
pet imaging
image quality
high resolution
contrast enhanced
magnetic resonance imaging
lymph node
benign prostatic hyperplasia
photodynamic therapy
mass spectrometry